Saturday 17 October 2026
Export MDAI’s income statement to Excel — free account
Spectral AI, Inc.
MDAI Healthcare Medical Devices
Spectral AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $19.7 million, down 33.6% from fiscal 2024. In the quarter to June 2026, revenue fell 30.4%, EPS grew 58.1%, free cash flow fell 21.9% and total debt rose 44.9%, each against the same quarter a year earlier.
1.51
0.03
−1.95%
Follow MDAI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Altman Z-Score |
(3.29) | (4.10) | (5.22) | 12.57 | — | — | — |
P/S ratio |
1.92 | 1.72 | 1.97 | 0.00 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(11.78) | (21.13) | (19.84) | 2.81 | — | — | — |
Beneish M-Score |
(2.68) | (4.06) | (6.53) | — | — | — | — |
P/Operating CF |
(14.76) | 108.22 | (15.01) | (441.56) | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 11.01 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 11.01 | — | — | — |
EV/Sales |
1.41 | 1.58 | 1.72 | 0.00 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
(2.80) | (5.07) | (2.35) | (101.42) | — | — | — |
EV/FCF |
(2.80) | (5.07) | (2.35) | (101.42) | — | — | — |
Quick Ratio |
0.81 | 0.43 | 0.58 | 2.58 | 0.26 | 0.00 | — |
Current Ratio |
0.94 | 0.57 | 0.80 | 2.77 | 0.37 | 0.00 | — |
Net Debt/EBITDA |
1.31 | 0.86 | 0.39 | 6.82 | 0.22 | 0.00 | — |
Debt/Assets |
25.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.97) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
1.17 | 2.60 | 1.23 | 0.19 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.31 | 0.61 | 0.63 | 0.40 | 1.74 | 0.00 | — |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| 116.67% | 338.35% | (405.44%) | 65.97% | 4.56% | 0.00% | — | |
| (45.20%) | (133.04%) | (141.83%) | (2.13%) | (0.37%) | (0.85%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1.80%) | — |
Return on Tangible Assets |
827.43% | 201.57% | 838.52% | (25.69%) | 25.55% | 0.50% | — |
Average Days of Receivables |
23.53 | 30.91 | 47.42 | 33.01 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
89.20% | 67.12% | 115.55% | 53.15% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.67% | 3.49% | 6.88% | 4.55% | — | — | — |
Graham Net Nets |
(0.20) | (0.18) | (0.07) | 0.08 | — | — | — |
Graham Number |
1.19 | 2.76 | 2.02 | 0.00 | — | — | — |
Earnings Yield |
(20.64%) | (29.68%) | (59.13%) | (2.21%) | — | — | — |
Free Cash Flow Yield |
(26.34%) | (18.12%) | (37.15%) | (0.88%) | — | — | — |
Revenue per Share |
0.74 | 1.65 | 1.28 | 1.93 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.37) | (0.51) | (0.94) | (0.09) | (0.13) | 0.00 | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.37) | (0.51) | (0.94) | (0.09) | (0.13) | 0.00 | — |
Cash per Share |
0.58 | 0.29 | 0.34 | 1.08 | 0.12 | 0.00 | — |
Shareholders Equity per Share |
(0.22) | (0.40) | (0.12) | 0.91 | (3.35) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(0.22) | (0.40) | (0.12) | 0.91 | (3.35) | 0.00 | — |
Free Cash Flow |
(9.92) | (9.20) | (13.24) | (1.16) | (0.83) | — | — |
Working Capital |
(1.17) | (7.52) | (2.50) | 11.31 | (1.85) | (0.14) | — |
Net Current Asset Value |
(7.68) | (9.22) | (2.50) | 10.97 | (273.85) | (0.14) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
4.22 | 294.00 | 60.17 | 27.05 | — | — | — |
Cash ROIC |
(65.24%) | 439.30% | (429.73%) | (4.44%) | 4.12% | 0.00% | — |
Accounts Receivable Turnover |
10.42 | 12.20 | 7.78 | 0.00 | — | — | — |
Accounts Payable Turnover |
3.04 | 4.85 | 3.74 | 0.00 | — | — | — |
Inventory Turnover |
16.98 | 49.79 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
102.44 | 90.32 | 96.24 | 69.30 | — | — | — |
Days of Inventory on Hand |
28.52 | 9.51 | 8.25 | 0.00 | — | — | — |
Average Receivables |
1.89 | 2.43 | 2.32 | — | — | — | — |
Average Payables |
3.52 | 3.36 | 2.72 | — | — | — | — |
Average Inventory |
0.63 | 0.33 | — | — | — | — | — |
Average Assets |
16.75 | 11.39 | 14.70 | 136.41 | 127.14 | 0.08 | — |
Average Common Equity |
(6.49) | (4.48) | 5.14 | (4.41) | (10.40) | 116.10 | — |
Columns are period end dates